4-Chloro-5-methoxy-2-pyridin-2-ylpyrimidine, 97.0%, 250mg

4-Chloro-6-fluoroquinoline>98.0%(GC)5g

3-chloro-N-ethylpropanamide, 95.0%, 1g

ROTI®Histofix, 10 l

(R)-2-Amino-3-(3-(trifluoromethoxy)phenyl)propanoic acid, 95%, 1g

dNTP-Set 1, 5 x 4 x 25 µmol (250 µl), 100 mM

2,6-Dimethylphenyl (2,4-dimethoxyphenyl)(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)carbamate, 98%, 10mg

1-[3-(1-methyl-1h-pyrazol-4-yl)phenyl]methanamine dihydrochloride, 98%, 250mg

(9H-fluoren-9-yl)methyl (S)-(1-(4-(tert-butoxy)phenyl)-3-hydroxypropan-2-yl)carbamate, 95+%, 1g

Bromoethane, min 99.5%, for synthesis, 250 ml, glass packaging

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)morpholine, 95.0%, 100mg

[(5-Bromopentyl)oxy](tert-butyl)dimethylsilane, 95%, 5g

2-(2-Aminoethyl)pyridine, 98.0%, 1g